Journal of Cancer Genetics And Biomarkers

Aims and Scope

The Journal of Cancer Genetics and Biomarkers aims to provide a platform for the dissemination of high-quality research in the field of cancer genetics and biomarkers. The journal publishes original research articles, reviews, and perspectives that focus on the genetic and molecular basis of cancer, and the identification and validation of biomarkers for early detection, diagnosis, prognosis, and treatment of cancer.

The journal's scope includes, but is not limited to, the following areas:

• Cancer Genetics: Studies that investigate the genetic and epigenetic changes that contribute to the development and progression of cancer.
• Cancer Biomarkers: Identification and validation of circulating tumor DNA (ctDNA), microRNAs, and proteomics for use in cancer detection and monitoring.
• Genetic Mutations and Cancer: Research on genomic profiling of tumors, germline mutations, and oncogenes that drive cancer development and progression.
• Molecular Pathways: Studies on molecular pathways like DNA repair, oncogenic signaling, and epigenetic modifications that contribute to cancer.
• Tumor Heterogeneity: Research on the diversity within tumor cell populations and its implications for treatment resistance and cancer recurrence.
• Immunotherapy and Immune Response: Exploration of immune checkpoint inhibitors, cancer immunotherapy biomarkers, and the tumor microenvironment (TME) in cancer treatment.
• Technological Advances: Development and application of next-generation sequencing (NGS), liquid biopsy techniques, and CRISPR in cancer research.
• Clinical Applications: Translational research bridging laboratory findings with clinical practice, focusing on precision oncology and personalized medicine.

The Journal of Cancer Genetics and Biomarkers welcomes submissions from researchers working in the field of cancer genetics and biomarkers, and aims to be a leading forum for the dissemination of new findings and ideas in this rapidly-evolving field.

JCGB encourages the submission of manuscripts from all areas of cancer research, including basic and clinical research, laboratory studies, and animal models. The journal particularly welcomes submissions focusing on identifying and delineating biomarkers associated with cancer risk and prognosis, assessing and validating cancer biomarkers, and understanding the underlying biology, genomics and epigenetics of cancer.

Contributions from the following research areas are invited but not limited to the following branches :

• Cancer Genetics
• Cancer Biomarkers
• Next Generation Sequencing (NGS) in Cancer
• Liquid Biopsy for Cancer Detection
• Circulating Tumor DNA (ctDNA)
• Genomic Profiling of Tumors
• Cancer Genome Atlas
• Tumor Microenvironment (TME)
• Epigenetic Modifications in Cancer
• Single Cell Genomics in Cancer
• Gene Editing Technologies (CRISPR) in Cancer Research
• Immune Checkpoint Inhibitors and Biomarkers
• Immunohistochemical Biomarkers
• Precision Oncology
• Cancer Stem Cells and Genetics
• Germline Mutations in Cancer
• Oncogenes and Tumor Suppressor Genes
• Molecular Pathways in Cancer
• BiomarkerDriven Cancer Therapies
• Cancer Immunotherapy Biomarkers
• Hereditary Cancer Syndromes
• Pharmacogenomics in Cancer Treatment
• Somatic Mutations in Cancer
• Genetic Predisposition to Cancer
• Cancer Risk Stratification
• Personalized Cancer Vaccines
• Biomarker Discovery and Validation
• Tumor Heterogeneity
• MicroRNAs as Cancer Biomarkers
• Proteomics in Cancer Biomarkers
• ExosomeDerived Biomarkers in Cancer
• DNA Repair Pathways in Cancer
• NonCoding RNAs in Cancer
• Cancer Metastasis Biomarkers
• Synthetic Lethality in Cancer
• Molecular Diagnostics in Cancer
• Targeted Cancer Therapies
• Biomarkers for Cancer Prognosis
• Cancer Epigenetics
• Oncofetal Antigens as Biomarkers
• Next Generation Immunotherapies
• Cell Free DNA (cfDNA) in Cancer Detection
• Biomarker Based Clinical Trials
• Cancer Gene Panels
• Liquid Biopsy for Minimal Residual Disease
• Neo antigens in Cancer Immunotherapy
• Multi Omics Approaches in Cancer
• Genomic Instability in Cancer
• Clonal Evolution in Cancer
• Bioinformatics in Cancer Genomics
• Epi transcriptomics in Cancer
• Cancer Biomarkers in Personalized Medicine
• Molecular Imaging of Cancer Biomarkers
• Cancer Immunogenomics
• Organoids in Cancer Research
• Tumor Infiltrating Lymphocytes (TILs)
• Cancer Neoepitopes
• Spatial Genomics in Cancer
• AI and Machine Learning in Cancer Genomics
• Radio genomics
• Functional Genomics in Cancer
• Epigenome Editing in Cancer
• Molecular Profiling of Liquid Biopsies
• Cancer Evolution and Adaptation
• Cancer Metabolism Biomarkers
• Pan Cancer Analysis
• Tumor Dormancy Biomarkers
• Cytokines and Cancer Biomarkers
• Metabolomics in Cancer
• Genetic Testing for Cancer Susceptibility
• Mitochondrial DNA in Cancer
• Oncogenic Signalling Pathways
• Cancer Gene Therapy

About Special Issue

The journal plans to publish special issues focusing on cutting-edge topics and emerging trends in cancer genetics and biomarkers. These issues bring together contributions from leading experts in the field, offering comprehensive insights into the latest advancements.

​
The journal also seeks to promote interdisciplinary collaborations between researchers, clinicians, and healthcare professionals. JCGB encourages the submission of manuscripts that contribute to the advancement of cancer genetics and biomarker research and will be of great benefit to the cancer research community.